Yale New Haven Psychiatric Hospital, a world leader in clinical care, research and education, is now offering transcranial magnetic stimulation (TMS) treatment with the Magstim Rapid2 Therapy System to patients with treatment-resistant major depressive disorder.
Dr. Robert Ostroff, Co-Medical Director, Interventional Psychiatric Services, Yale New Haven Psychiatric Hospital, and his colleagues discuss adding transcranial magnetic stimulation therapy to their practice in a recent article in the New Haven Register.
Items marked with* are investigational devices and for research use only. CAUTION - Investigational Device. Limited by Federal (or United States) law to investigational use.